Initial Treatment of Pediatric Graves’ Disease with Methimazole: A Retrospective Follow-up Study

Antithyroid drugs are widely used in the therapy of Graves’ disease (GD), and methimazole (MMI) is preferred for treatment of pediatric GD. The recommended initial dosage of MMI is 0.5–1.0 mg/kg/d for pediatric GD, although there are few studies on the optimal MMI dosage for initial treatment in chi...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Matsushita, Rie, Nakagawa, Yuichi, Nagata, Eiko, Satake, Eiichiro, Sano, Shinichiro, Yamaguchi, Rie, Fujisawa, Yasuko, Masui, Ayako, Nakanishi, Toshiki, Endo, Akira, Kagawa, Jiro, Ohzeki, Takehiko
Formato: Artigo
Lenguaje:Inglês
Publicado: The Japanese Society for Pediatric Endocrinology 2010
Materias:
Original Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3687628/
https://ncbi.nlm.nih.gov/pubmed/23926385
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1297/cpe.19.101
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares